| Isolated limb perfusion with the tumor‐targeting human monoclonal antibody–cytokine fusion protein L19‐TNF plus melphalan and mild hyperthermia in patients with locally … F Papadia, V Basso, R Patuzzo, A Maurichi, A Di Florio, L Zardi, E Ventura, ... Journal of surgical oncology 107 (2), 173-179, 2013 | 109 | 2013 |
| TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells E Ventura, M Weller, W Macnair, K Eschbach, C Beisel, C Cordazzo, ... Journal of cell science 131 (1), jcs209619, 2018 | 42 | 2018 |
| Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma E Papa, M Weller, T Weiss, E Ventura, I Burghardt, E Szabó Cell death & disease 8 (12), 3210, 2017 | 35 | 2017 |
| A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis‐associated extra type III domain B E Balza, F Sassi, E Ventura, A Parodi, S Fossati, W Blalock, B Carnemolla, ... International journal of cancer 125 (4), 751-758, 2009 | 34 | 2009 |
| Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the BC loop of the type III repeat 8 E Ventura, F Sassi, A Parodi, E Balza, L Borsi, P Castellani, B Carnemolla, ... PLoS One 5 (2), e9145, 2010 | 26 | 2010 |
| Cutting edge: ERK1 mediates the autocrine positive feedback loop of TGF-β and furin in glioma-initiating cells E Ventura, M Weller, I Burghardt The Journal of Immunology 198 (12), 4569-4574, 2017 | 20 | 2017 |
| Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report E Ventura, E Balza, L Borsi, G Tutolo, B Carnemolla, P Castellani, L Zardi BMC biotechnology 11, 1-8, 2011 | 13 | 2011 |
| Endoglin and TGF-β signaling in glioblastoma I Burghardt, E Ventura, T Weiss, JJ Schroeder, K Seystahl, C Zielasek, ... Cell and Tissue Research 384, 613-624, 2021 | 11 | 2021 |
| RBL2/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis E Ventura, F Pentimalli, A Giordano Oncoscience 5 (11-12), 278, 2018 | 8 | 2018 |
| Use of uteroglobin for the engineering of polyvalent, polyspecific fusion proteins E Ventura, F Sassi, S Fossati, A Parodi, W Blalock, E Balza, P Castellani, ... Journal of biological chemistry 284 (39), 26646-26654, 2009 | 8 | 2009 |
| Progranulin oncogenic network in solid tumors E Ventura, G Ducci, R Benot Dominguez, V Ruggiero, A Belfiore, E Sacco, ... Cancers 15 (6), 1706, 2023 | 7 | 2023 |
| C6: a monoclonal antibody specific for a fibronectin epitope situated at the interface between the oncofoetal extra-domain B and the repeat III8 E Ventura, C Cordazzo, R Quarto, L Zardi, C Rosano Plos one 11 (2), e0148103, 2016 | 6 | 2016 |
| Complexity of progranulin mechanisms of action in mesothelioma E Ventura, C Xie, S Buraschi, A Belfiore, RV Iozzo, A Giordano, ... Journal of Experimental & Clinical Cancer Research 41 (1), 333, 2022 | 5 | 2022 |
| RBL1/p107 expression levels are modulated by multiple signaling pathways E Ventura, CA Iannuzzi, F Pentimalli, A Giordano, A Morrione Cancers 13 (19), 5025, 2021 | 5 | 2021 |
| Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma HG Wirsching, M Silginer, E Ventura, W Macnair, I Burghardt, M Claassen, ... Molecular Therapy-Oncolytics 20, 166-174, 2021 | 3 | 2021 |
| Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells E Ventura, A Belfiore, RV Iozzo, A Giordano, A Morrione American Journal of Physiology-Cell Physiology 325 (2), C391-C405, 2023 | 2 | 2023 |
| Profiling Metabolic and Signaling Phenotype of Bladder Cancer Cell Lines G Ducci, V Pasquale, S Rota, E Arrigoni, G Campioni, E Ventura, ... The FASEB Journal 36, 2022 | 1 | 2022 |
| Progranulin modulates RYK and EGFR activity in mesothelioma cells E Ventura, R Iozzo, A Belfiore, A Giordano, A Morrione Journal of Biological Chemistry 299 (3), S731, 2023 | | 2023 |
| Mechanisms of action and regulation of the progranulin/EphA2 axis in mesothelioma E Ventura, S Buraschi, SJ Williams, A Belfiore, RV Iozzo, A Giordano, ... Cancer Research 82 (12_Supplement), 97-97, 2022 | | 2022 |
| Pharmacological reactivation of RBL2/p130 could be an effective antitumoral strategy for malignant pleural mesothelioma A Costa, IM Forte, E Ventura, F Pentimalli, A Giordano The FASEB Journal 36, 2022 | | 2022 |
